In 2024, the FDA’s approval of omalizumab for food allergies dominated the news in the field of allergy treatment. Other popular topics included the impact of media on food allergies, social pressures, and bullying. The controversial Uber Eats Super Bowl commercial depicting an allergic reaction sparked discussion. Additionally, discussions on whether better drugs or food are needed for food allergy treatment, oral allergy syndrome, the approval of Xolair and dupilumab for food allergies, and the connection between bullying and food allergies were highlighted. Studies also showed that changes in antibody levels could predict the resolution of peanut allergies in children.
Source link
Top 10 food allergy stories of 2024
